 The FDA has issued a statement restricting the use of Intercept Pharmaceuticals Incs NASDAQ: ICPT Ocaliva obeticholic acid in primary biliary cholangitis PBC patients with advanced cirrhosis. PBC is a rare, chronic disease affecting the ducts in the liver that carry bile, which helps with digestion. 